Five things for pharma marketers to know: Tuesday, November 12, 2019
Google secretly gathered health data; Adams named Kaiser Permanente interim CEO; Private equity firm makes offer to buy Walgreens.
Roundup
Five things for pharma marketers to know: Monday, November 11, 2019
Officials find potential cause for vaping related illness; Trump proposes raising the age to buy e-cigarettes; Celgene rare disease drug wins approval.
Five things for pharma marketers to know: Friday, November 8, 2019
New York opioid trial set for January; Juul stops selling mint flavor; Vaping lung illness cases pass 2,000, deaths increase to 39.
Five things for pharma marketers to know: Thursday, November 7, 2019
CVS to close 22 stores; CRISPR passes safety test; Kentucky Gov.-elect to rescind Medicaid work requirement.
Five things for pharma marketers to know: Wednesday, November 6, 2019
Walgreens seeking private equity buyer; People increasingly turning to Google, social media for medical advice; White House will not support Nancy Pelosi’s drug pricing bill.
Five things for pharma marketers to know: Tuesday, November 5, 2019
Religious exemptions for vaccines have risen; FDA’s decision on Biogen Alzheimer’s drug may be political; Shortage of immune globulin affects cancer, epilepsy treatments.
Five things for pharma marketers to know: Monday, November 4, 2019
MM&M and PRWeek unveil the 2019 Health Influencer 50; Google acquires Fitbit; President Donald Trump nominates Dr. Stephen Hahn as FDA lead.
Five things for pharma marketers to know: Friday, November 1, 2019
Some Democrats shift message on drug-price legislation; Vaping deaths rise to 37; FTC investigates Altria role in replacing Juul CEO.
Five things for pharma marketers to know: Thursday, October 31, 2019
Former Juul executive sues company; Purdue financial details revealed; Amgen cuts 180 jobs.
Five things for pharma marketers to know: Wednesday, October 30, 2019
After tests, J&J says recalled baby powder doesn’t have asbestos; Federal judge blocks Alabama abortion law; Marketing chief, other execurives depart Juul.
Five things for pharma marketers to know: Tuesday, October 29, 2019
Facebook’s big announcement at HLTH; Report: Google parent makes bid for Fitbit; Walgreens to close 150 clinics.
Five things for pharma marketers to know: Monday, October 28, 2019
Government warns of hospital equipment shortages; Panel says Pelosi drug price bill could be unconstitutional; Fewer cases of vaping illness reported.
Five things for pharma marketers to know: Friday, October 25, 2019
Verily partners with Palo Alto VA; Amgen drops list price of Repatha; Amazon acquires Health Navigator.
Five things for pharma marketers to know: Thursday, October 24, 2019
Nancy Pelosi’s drug price bill heads to full vote; FDA proposes cancer warnings on breast implants; NIH, Gates Foundation pledge $200 million to HIV, sickle cell cures.
Five things for pharma marketers to know: Wednesday, October 23, 2019
Biogen resurrects Alzheimer’s drug in light of new analysis; ACA premiums expected to drop next year; Novartis gene therapy Zolgensma beats sales expectations.
Want to read more?
Please login or register first to view this content.
